 Abiraterone acetate binds in the active site of the enzyme  and coordinates the heme iron through its pyridine nitrogen, mimicking the subtrate.Since 2014, galeterone has been in phase III clinical trials for castration-resistant prostate cancer.Ketoconazole is an older CYP17A1 inhibitor that is now little used.